ANNA BULMAHN: Open Payments
NPI 1639843428 · PORTAGE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,851 in 87 payments from 21 companies in 2025. Trend: 2023 $3,148 · 2024 $2,022 · 2025 $1,851
Food & beverage: $1,806Education: $45
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 15 | $358 |
| ABBVIE INC. | 14 | $251 |
| RECORDATI_RARE_DISEASES_INC. | 10 | $192 |
| Lilly USA, LLC | 7 | $173 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $141 |
| Amgen Inc. | 6 | $111 |
| PFIZER INC. | 4 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $67 |
| Novo Nordisk Inc | 4 | $61 |
Products named: Korlym, ISTURISA, XIFAXAN, UBRELVY, MOUNJARO, REPATHA, SYNTHROID, NURTEC ODT.
Industry payments across IN — which companies pay providers there.
